Vimarsana
Biggest News Aggregation in the World

Page 29 - Use Authorization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Use Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Use Authorization Today - Breaking & Trending Today

Pfizer Inc.: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union - Vimarsana News

Pfizer Inc.: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union

Published: September 12, 2022

CHMP recommendation based on favorable data from Omicron-adapted vaccines The Omicron BA.4/BA.5 bivalent COVID-19 booster vaccine combines 15-ug of mRNA encoding the wild-type spike protein

Source: finanznachrichten.de
Related Topics:
United StatesUnited KingdomSylke MaasAlbert BourlaUgur SahinFosun PharmaInternational Coalition Of Medicines Regulatory AuthoritiesPfizer IncEuropean UnionCommittee For Medicinal Products Human UseCenters For DiseaseDrug AdministrationWorld Health OrganizationEuropean CommissionExchange CommissionRoche GroupEuropean Medicines AgencyMedicinal ProductsHuman UseChief Executive OfficerInternational CoalitionMedicines Regulatory AuthoritiesMarketing Authorization HolderEmergency Use AuthorizationUse Authorization
The U.S. Department of Defense Awards CytoSorbents an Approximately $2.0M Contract to Support HemoDefend-BGA™ Development for Life-saving Universal Plasma - Vimarsana News

The U.S. Department of Defense Awards CytoSorbents an Approximately $2.0M Contract to Support HemoDefend-BGA™ Development for Life-saving Universal Plasma

Published: September 9, 2022

PRINCETON, N.J., Sept. 9, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions i...

Source: businessinsider.com
Related Topics:
United StatesMaryann GrudaEric KimAmy VogelCytosorbent HemodefendVincent CapponiDepartment Of DefenseMaterial CommandUs Department Of Defense DoReady Blood Group AntibodyUs Army Medical Research Acquisition ActivityDevelopment ProgramCasualty Care Research ProgramEuropean UnionUs ArmyDefense Medical ResearchBlood InstituteCytosorbents CorporationNational HeartUs Department Of HealthHuman ServicesCasualty Care ResearchNational Institutes Of HealthResearch ProgramsWorld Health Organization
CytoSorbents to Present at the H.C. Wainwright 24th Annual Global Investment Conference - Vimarsana News

CytoSorbents to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Published: September 7, 2022

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Source: prnewswire.com
Related Topics:
United StatesEric KimAmy VogelPhillip ChanUs Department Of HealthHuman ServicesMaterial CommandNational Institutes Of HealthUs AirEuropean UnionUs ArmyBlood InstituteCytosorbents CorporationNational HeartSorbents CorporationChief Executive OfficerAnnual Global Investment ConferenceInvestor RelationsUse AuthorizationDevice DesignationsTimely Antithrombotic Removal TicagrelorNational InstitutesOperations CommandAir Force Material CommandPrivate Securities Litigation Reform Act
Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older - Vimarsana News

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older

Published: August 31, 2022

Investegate announcements from BioNTech SE, Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older

Source: investegate.co.uk
Related Topics:
United StatesUnited KingdomSylke MaasAlbert BourlaUgur SahinFosun PharmaCenters For DiseaseDrug AdministrationAdvisory Committee On Immunization PracticesExchange CommissionPfizer IncEuropean UnionEuropean Medicines AgencyRoche GroupUse AuthorizationAdapted BivalentEmergency Use AuthorizationChief Executive OfficerDisease ControlAdvisory CommitteeImmunization PracticesBiologics License ApplicationMarketing Authorization HolderCoronavirus DiseaseVaccine Adverse Event Reporting System
Should Pfizer Investors Be Worried About Moderna's Lawsuits? - Vimarsana News

Should Pfizer Investors Be Worried About Moderna's Lawsuits?

Published: August 31, 2022

Pfizer and BioNTech plan to aggressively defend against Moderna's claims of patent infringement.

Source: fool.com
Related Topics:
Drug AdministrationShould PfizerUse AuthorizationChief Legal Officer Shannon Thyme KlingerMarket Commitment